Patients with chronic three-vessel disease in a 15-year follow-up study: genetic and non-genetic predictors of survival.

Item

http://www.wikidata.org/entity/Q36153982

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Patients with chronic three-ve ...... enetic predictors of survival.

@ast

Patients with chronic three-ve ...... enetic predictors of survival.

@en

type

Item

label

Patients with chronic three-ve ...... enetic predictors of survival.

@ast

Patients with chronic three-ve ...... enetic predictors of survival.

@en

prefLabel

Patients with chronic three-ve ...... enetic predictors of survival.

@ast

Patients with chronic three-ve ...... enetic predictors of survival.

@en

P1476

Patients with chronic three-ve ...... enetic predictors of survival.

@en

P2093

Anna Vašků

http://www.w3.org/2001/XMLSchema#string

Ladislav Groch

http://www.w3.org/2001/XMLSchema#string

Monika Pávková-Goldbergová

http://www.w3.org/2001/XMLSchema#string

Ota Hlinomaz

http://www.w3.org/2001/XMLSchema#string

P2860

Association between serum interleukin-6 concentration and mortality in patients with coronary artery disease

Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells

The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity

Association of apolipoprotein E genotypes with lipid levels and coronary risk

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Apolipoprotein E polymorphism, age and coronary heart disease

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review

MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers

Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists.

P304

e278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000000278

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jan Machal

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269765615

http://www.w3.org/2001/XMLSchema#string

P698

25526459

http://www.w3.org/2001/XMLSchema#string

P932

4603099

http://www.w3.org/2001/XMLSchema#string